Global Clinical Impact: Education, Tools, and Resources to Optimize the Care of Patients With Relapsed/Refractory MCL

Review latest practice-changing data and gain global expert insight on the integration of emerging BTK inhibitors into the care of patients with relapsed/refractory MCL including a roundtable of regional impacts of the data an on-demand webcast focused commentaries and Interactive Decision Support Tools for personalized management recommendations from internationally recognized experts.

Share

Program Content

Activities

FAQs: BTKis for R/R MCL
FAQs: Optimizing the Care of Patients With Relapsed/Refractory MCL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 05, 2023

Noncovalent BTKis in MCL
Noncovalent BTK Inhibitors in Mantle Cell Lymphoma: What You Should Know
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 20, 2022

Expires: October 19, 2023

Activities

BTK Inhibitors in R/R MCL
Experts Discuss Advances in the Use of BTK Inhibitors for the Treatment of Relapsed/Refractory MCL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 17, 2023

Expires: January 16, 2024

Activities

BTK Inhibitors in MCL
Differences in Mechanism of Action and Selectivity of Covalent and Non-Covalent BTK Inhibitors
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: November 29, 2022

Expires: November 28, 2023

Activities

BTK Inhibitors in R/R MCL
Experts Discuss Advances in the Use of BTK Inhibitors for the Treatment of Relapsed/Refractory MCL
Video
Congratulations: You achieved a completion on 04/09/2022

Released: March 20, 2023

Expires: March 19, 2024

Activities

IDST: MCL
Interactive Decision Support Tool: MCL Expert Treatment Guidance
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: April 21, 2023

IDST: Global MCL Therapy
Interactive Decision Support Tool: Global MCL Expert Treatment Guidance
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: August 29, 2023

Faculty

cover img faculity

Stephen Ansell, MD, PhD

Professor of Medicine
Department of Hematology
Mayo Clinical Cancer Center
Rochester, Minnesota

cover img faculity

Ian Flinn, MD, PhD

Chief Scientific Officer
OneOncology
Nashville, Tennessee

cover img faculity

Christopher R. Flowers, MD, MS

Department Chair
Department of Lymphoma/Myeloma, Division of Cancer Medicine
University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Olivier Hermine, MD, PhD

Head Department of Clinical Hematology
Head National Center of Mastocytosis
Universite Sorbonne Paris Cite
Laboratory of cellular and molecular Mechanisms of hematological disorders and therapeutic implications
Coordinator Labex on Red Cell and Iron Metabolism
Necker Hospital and Imagine Institute
Paris, France

cover img faculity

Marco Ladetto, MD

Associate Professor in hematology
University of Eastern Piedmont
Director of SCDU Hematology Division
AO SS Antonio E Biagio e Cesare Arrigo
Alessandria, Piedmont, Italy

cover img faculity

John P. Leonard, MD

Senior Associate Dean for Innovation and initiatives
Chair (Interim), Weill Department of Medicine
Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
Weill Cornell Medicine/NewYork-Presbyterian
New York, New York

cover img faculity

Ana Marin-Niebla, MD, PhD

Hematology Consultant, Lymphoma Unit
Vall d'Hebron Institute of Oncology, Hematology Department
Hospital Universitario Vall d'Hebron
Barcelona, Spain

cover img faculity

Guilherme Perini, MD

Head
Center of Excellence in Lymphoma
Hospital Israelita Albert Einstein
Sao Paulo, Brazil

cover img faculity

Max Topp, MD

Professor
Head of Hematology
Department of Hematology
Universitätsklinikum Würzburg
Würzburg, Germany

cover img faculity

Julie M. Vose, MD, MBA

Payne Presidential Chair
Chief, Division of Hematology/Oncology
University of Nebraska Medical Center
Buffett Cancer Center
Omaha, Nebraska

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Lilly.

Lilly